IP Library Granted Patent US 10,857,194
Granted Patent B2
US 10,857,194 · App. 16/275,778 · Granted Dec 8, 2020

Hybrid herbal and drug composition and method of formulation

Inventor: Shui Yin Lo (Arcadia, CA)
A61K36/481A61K31/203A61K31/4418A61K31/51A61K31/59A61K33/06A61K33/22A61K33/30A61K33/42A61K35/32A61K35/586A61K35/64A61K35/644A61K36/18A61K36/232
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,857,194
App. No.
16/275,778
Granted
Dec 8, 2020
Kind
B2
Abstract

A hybrid herbal and drug composition includes an amount of Chinese herb about 0.01 to 5% by weight of the composition; an amount of animal-based matter about 0.01 to 5% by weight of the composition; an amount of vitamin about 0.01 to 5% by weight of the composition; an amount of mineral about 0.01 to 5% by weight of the composition; an amount of hormone about 0.01 to 5% by weight of the composition; an amount of factory produced product about 0.01 to 5% by weight of the composition; and an amount of the purified water about 70% to 99.94% by weight of the composition.

Claims (15)

1. A hybrid herbal and drug composition, the composition comprising:

a first solution M consisting of:

at least one homeopathic substance,

an amount of Chinese herb about 0.01 to 5% by weight of the composition, the Chinese herb including at least one of the following: renshen, xiyangshen, dongchongxiacao, lingzhi, dang shen, huangqi, baizhu, xianhecao, buguzhi, nuzhenzi, fuling, wuweizi, danggui, fuling, shudihuang, gouqizi, xuanzhi, gancao, and suan zaoren,

an amount of animal-based matter about 0.01 to 5% by weight of the composition, the animal-based matter including at least one of the following: lurong, gui ban, bei jia, and fengmi;

an amount of vitamin about 0.01 to 5% by weight of the composition, the vitamin including at least one of the following: vitamin A, vitamin E, vitamin D, vitamin K, vitamin B complexes, vitamin B1, vitamin B2, vitamin B3, vitamin B6, vitamin B12, and vitamin C;

an amount of mineral about 0.01 to 5% by weight of the composition, the mineral including at least one of the following: calcium, phosphorous, magnesium, zinc, iron, copper, manganese, chromium, selenium, iodine, potassium, and boron;

an amount of hormone about 0.01 to 5% by weight of the composition; and

an amount of factory produced product about 0.01 to 5% by weight of the composition, the factory produced product including at least one of the following: metformin, glucophage, victoza, januvia, amaryl, actos, invokana, levemir, glucotrol, lantus, glimepiride, byetta, bydureon, farxiga, humalog, trastuzumab, pertuzumab, tamoxifen, palbociclib, ribociclib, everolimus, doxorubicin, epirubicin, paciitaxel, docetaxei, abitrexate, abraxane, afatinib, afinitor, alecensa, alectinib, alirnta, alunbrig, atezolizurnab, and avastin;

and an amount of the purified water about 70% to 99.94% by weight of the composition; the first solution M being diluted in an inert gas environment and polarized with an electrical field.

2. The hybrid herbal and drug composition of claim 1 , wherein each of an amount of the Chinese herb selected from the group is 0.1 to 100% by weight of a total amount of the Chinese herb.

3. The hybrid herbal and drug composition of claim 1 , wherein each of an amount of the animal-based matter selected from the group is 0.1 to 100% by weight of a total amount of the animal-based matter.

4. The hybrid herbal and drug composition of claim 1 , wherein each of an amount of the factory produced product selected from the group is 0.1 to 100% by weight of a total amount of the factory produced product.

5. The hybrid herbal and drug composition of claim 1 , wherein each of an amount of the vitamin selected from the group is 0.1 to 100% by weight of a total amount of the vitamin.

6. The hybrid herbal and drug composition of claim 1 , wherein each of an amount of the mineral selected from the group is 0.1 to 100% by weight of a total amount of the mineral.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2020
From: LO, SHUI YIN
To: AMERICAN QUANTUM HEALTH INC.; LO, SHUI YIN
Reel/Frame 052265/0713 →
Continuity (2)
Provisional Application 62630746 · Feb 14, 2018
Related Publication 20190247455A1 · Aug 15, 2019